Reverse epidemiology in hemodialysis patients. Lessons from Japanese registries

Nephrologie et Therapeutique

Volumn 4, Issue 4, 2008, Pages 223-227

  Shoji, Tetsuo ^a,b   Tsubakihara, Yoshiharu ^b,c   Nakai, Shigeru ^b,d   Nishizawa, Yoshiki ^a,e  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Scientific Academic Committee of the Japanese Society for Dialysis Therapy   (Japan)

^c OSAKA GENERAL MEDICAL CENTER   (Japan)

^d FUJITA HEALTH UNIVERSITY   (Japan)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE REGISTRY; DYSLIPIDEMIA; EDITORIAL; FATALITY; HEMODIALYSIS PATIENT; HIGH RISK POPULATION; HUMAN; JAPANESE; MALNUTRITION; RISK FACTOR;

CARDIOVASCULAR DISEASES; DYSLIPIDEMIAS; HUMANS; JAPAN; KIDNEY FAILURE, CHRONIC; MALNUTRITION; RENAL DIALYSIS; SURVIVAL ANALYSIS;

EID: 45849152610     PISSN: 17697255     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nephro.2008.01.005     Document Type: Editorial

References (25)

1. Levey A.S., Beto J.A., Coronado B.E., et al. Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on cardiovascular disease. Am J Kidney Dis 32 (1998) 853-906
2. Degoulet P., Legrain M., Reach I., et al. Mortality risk factors in patients treated by chronic hemodialysis. Report of the diaphane collaborative study. Nephron 31 (1982) 103-110
3. Kalantar-Zadeh K., Kovesdy C.P., Derose S.F., et al. Racial and survival paradoxes in chronic kidney disease. Nat Clin Pract Nephrol 3 (2007) 493-506
4. Iseki K., and Fukiyama K. Long-term prognosis and incidence of acute myocardial infarction in patients on chronic hemodialysis. The Okinawa Dialysis Study Group. Am J Kidney Dis 36 (2000) 820-825
5. Iseki K., and Fukiyama K. Clinical demographics and long-term prognosis after stroke in patients on chronic haemodialysis. The Okinawa Dialysis Study (OKIDS) Group. Nephrol Dial Transplant 15 (2000) 1808-1813
6. Shoji T., Kawagishi T., Emoto M., et al. Additive impacts of diabetes and renal failure on carotid atherosclerosis. Atherosclerosis 153 (2000) 257-258
7. Shoji T., Nishizawa Y., Kawagishi T., et al. Intermediate-density lipoprotein as an independent risk factor for aortic atherosclerosis in hemodialysis patients. J Am Soc Nephrol 9 (1998) 1277-1284
8. Nishizawa Y., Shoji T., Maekawa K., et al. Intima-media thickness of carotid artery predicts cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 41 (2003) S76-S79
9. Shoji T., Emoto M., Shinohara K., et al. Diabetes mellitus, aortic stiffness, and cardiovascular mortality in end-stage renal disease. J Am Soc Nephrol 12 (2001) 2117-2124
10. Stenvinkel P., Heimburger O., Lindholm B., et al. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant 15 (2000) 953-960
11. Kalantar-Zadeh K., Abbott K.C., Salahudeen A.K., et al. Survival advantages of obesity in dialysis patients. Am J Clin Nutr 81 (2005) 543-554
12. Kakiya R., Shoji T., Tsujimoto Y., et al. Body fat mass and lean mass as predictors of survival in hemodialysis patients. Kidney Int 70 (2006) 549-556
13. Kalantar-Zadeh K., Kuwae N., Wu D.Y., et al. Associations of body fat and its changes over time with quality of life and prospective mortality in hemodialysis patients. Am J Clin Nutr 83 (2006) 202-210
14. Foley R.N., Parfrey P.S., Harnett J.D., et al. Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease. J Am Soc Nephrol 7 (1996) 728-736
15. Japanese Society for Dialysis Therapy: an overview of regular dialysis treatment in Japan (as of Dec. 31, 2001), in, Tokyo, Japanese Society for Dialysis Therapy, 2002, pp 567-597, 622-648.
16. Japanese Society for Dialysis Therapy: An overview of regular dialysis treatment in Japan as of Dec. 31, 2004, in, Tokyo, Japanese Society for Dialysis Therapy, 2005, pp 50-55.
17. Nishizawa Y., Shoji T., Ishimura E., et al. Paradox of risk factors for cardiovascular mortality in uremia: is a higher cholesterol level better for atherosclerosis in uremia?. Am J Kidney Dis 38 (2001) S4-S7
18. Shoji T., and Nishizawa Y. Chronic kidney disease as a metabolic syndrome with malnutrition-need for strict control of risk factors. Intern Med 44 (2005) 179-187
19. Suliman M., Stenvinkel P., Qureshi A.R., et al. The reverse epidemiology of plasma total homocysteine as a mortality risk factor is related to the impact of wasting and inflammation. Nephrol Dial Transplant 22 (2007) 209-217
20. Schwedler S.B., Metzger T., Schinzel R., et al. Advanced glycation end products and mortality in hemodialysis patients. Kidney Int 62 (2002) 301-310
21. Liu Y., Coresh J., Eustace J.A., et al. Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition. JAMA 291 (2004) 451-459
22. Nishizawa Y., Shoji T., Kakiya R., et al. Non-high-density lipoprotein cholesterol (non-HDL-C) as a predictor of cardiovascular mortality in patients with end-stage renal disease. Kidney Int Suppl (2003) S117-S120
23. Anavekar N.S., McMurray J.J., Velazquez E.J., et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 351 (2004) 1285-1295
24. Kovesdy C.P., Anderson J.E., and Kalantar-Zadeh K. Paradoxical association between body mass index and mortality in men with CKD not yet on dialysis. Am J Kidney Dis 49 (2007) 581-591
25. Herzog C.A., Ma J.Z., and Collins A.J. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med 339 (1998) 799-805